1. Home
  2. BKD vs EVO Comparison

BKD vs EVO Comparison

Compare BKD & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BKD
  • EVO
  • Stock Information
  • Founded
  • BKD 2005
  • EVO 1993
  • Country
  • BKD United States
  • EVO Germany
  • Employees
  • BKD N/A
  • EVO N/A
  • Industry
  • BKD Hospital/Nursing Management
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BKD Health Care
  • EVO Health Care
  • Exchange
  • BKD Nasdaq
  • EVO Nasdaq
  • Market Cap
  • BKD 1.6B
  • EVO 1.5B
  • IPO Year
  • BKD 2005
  • EVO 2021
  • Fundamental
  • Price
  • BKD $7.51
  • EVO $4.26
  • Analyst Decision
  • BKD Buy
  • EVO Buy
  • Analyst Count
  • BKD 5
  • EVO 2
  • Target Price
  • BKD $7.70
  • EVO $5.90
  • AVG Volume (30 Days)
  • BKD 3.2M
  • EVO 95.8K
  • Earning Date
  • BKD 08-06-2025
  • EVO 08-13-2025
  • Dividend Yield
  • BKD N/A
  • EVO N/A
  • EPS Growth
  • BKD N/A
  • EVO N/A
  • EPS
  • BKD N/A
  • EVO N/A
  • Revenue
  • BKD $3,015,786,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • BKD $8.40
  • EVO $10.08
  • Revenue Next Year
  • BKD N/A
  • EVO $10.99
  • P/E Ratio
  • BKD N/A
  • EVO N/A
  • Revenue Growth
  • BKD 4.14
  • EVO 1.50
  • 52 Week Low
  • BKD $4.45
  • EVO $2.84
  • 52 Week High
  • BKD $8.08
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • BKD 55.51
  • EVO 55.61
  • Support Level
  • BKD $6.65
  • EVO $3.64
  • Resistance Level
  • BKD $7.90
  • EVO $4.36
  • Average True Range (ATR)
  • BKD 0.27
  • EVO 0.09
  • MACD
  • BKD -0.03
  • EVO -0.01
  • Stochastic Oscillator
  • BKD 62.41
  • EVO 86.11

About BKD Brookdale Senior Living Inc.

Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: